Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

Sang Eun Yoon, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD, Young Hyeh Ko, MD, Kim Yeon Jeong, PhD, Park Donghyun, PhD

Blood (2019) 134 (Supplement_1): 1491.

https://doi.org/10.1182/blood-2019-130075

Published: 2019

Journal Articles

PD-L1 Expression in Patients with Primary Central Nervous System Diffuse Large B-Cell Lymphoma: Its Correlation with Serum Levels of Soluble Programmed Death-Ligand 1 (sPD-L1)

Inju Cho, MD PhD, Seok Jin Kim, MD PhD, Hansang Lee, MD, Young Hyeh Ko, MD

Blood (2019) 134 (Supplement_1): 1601.

https://doi.org/10.1182/blood-2019-123311

Published: 2019

Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Maria Elena Cabrera, Monica Bellei, MSc, PhD, Young Hyeh Ko, MD, Martina Manni, PhD, Steven M. Horwitz, MD, Carmino Antonio De Souza, MD PhD, John A. Radford, MD, Sabela Bobillo Varela, Maria Virginia Prates, MD, Andrés J M Ferreri, MD, Carlos Chiattone, MD, Michele Spina, MD, Julie M. Vose, MDMBA, Annalisa Chiappella, MD, Daniele Laszlo, MD, Dario Marino, MDPhD, Caterina Stelitano, Massimo Federico, MD

Blood (2017) 130 (Supplement 1): 4071.

https://doi.org/10.1182/blood.V130.Suppl_1.4071.4071

Published: 2017

Journal Articles

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

Blood (2016) 128 (22): 2921.

https://doi.org/10.1182/blood.V128.22.2921.2921

Published: 2016

Journal Articles

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Shin Dong-Yeop, MD PhD, Ho Sup Lee, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Dok Hyun Yoon, Jung Yong Hong, MD, Jee Hyun Kong, Kana Sakamoto, Young Hyeh Ko, MD, Kengo Takeuchi, MD PhD, Cheolwon Suh, Won Seog Kim

Blood (2016) 128 (22): 1820.

https://doi.org/10.1182/blood.V128.22.1820.1820

Published: 2016

Journal Articles

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

Monica Bellei, Francine M Foss, MD, Steven M Horwitz, MD, Luigi Marcheselli, Won Seong Kim, Maria Elena Cabrera, Ivan Dlouhy, MD, Arnon Nagler, Ranjana H Advani, MD, Emanuela Pesce, Young Hyeh Ko, MD, Virginia Martinez, Silvia Montoto, MD, Carlos Chiattone, Alison J. Moskowitz, MD, Michele Spina, Marina Cesaretti, Irene Biasoli, Massimo Federico

Blood (2016) 128 (22): 921.

https://doi.org/10.1182/blood.V128.22.921.921

Published: 2016

Journal Articles

Prevalence and Prognostic Impact of CD30 and EBV Co-Expression in Korean Patients with EBV-Positive DLBCL of the Elderly

Jung Yong Hong, MD, Keon Woo Park, MD, Young Hyeh Ko, MD, Seok Jin Kim, MD PhD, Won Seog Kim, MD PhD

Blood (2015) 126 (23): 5021.

https://doi.org/10.1182/blood.V126.23.5021.5021

Published: 2015

Journal Articles

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Blood (2015) 126 (23): 700.

https://doi.org/10.1182/blood.V126.23.700.700

Published: 2015

Journal Articles

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Dong-Yeop Shin, MD, Dok Hyun Yoon, Kana Sakamoto, MD, Jee Hyun Kong, MD, Young Hyeh Ko, MD PhD, Kengo Takeuchi, MD PhD, Cheolwon Suh, MD, PhD, Won Seog Kim, MD PhD

Blood (2014) 124 (21): 4443.

https://doi.org/10.1182/blood.V124.21.4443.4443

Published: 2014

Journal Articles

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

Sung Min Kim, Seung-Tae Lee, MD, Kyung Ju Ryu, Hee-Jin Kim, Sun-Hee Kim, Kwai Han Yoo, Young Hyeh Ko, MD PhD, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2014) 124 (21): 1622.

https://doi.org/10.1182/blood.V124.21.1622.1622

Published: 2014

Journal Articles

Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project.

Stefano A. Pileri, MD, Monica Bellei, Julie M Vose, MD, MBA, Joseph M. Connors, MD, Francine M. Foss, MD, Steven M. Horwitz, MD, Silvia Montoto, MD, Aaron Polliack, MD, Pier Luigi Zinzani, MD, Emanuele Zucca, MD, Young-Hyeh Ko, MD, Massimo Federico, MD

Blood (2012) 120 (21): 2650.

https://doi.org/10.1182/blood.V120.21.2650.2650

Published: 2012

Journal Articles

Aggressive NK Cell Leukemia (ANKL): Experience with 34 Patients and Therapeutic Potentials of L-Asparaginase and Allogeneic Hematopoietic Cell Transplantation - A Japan-Korea Multicenter Study for ANKL (ANKL07) -

Fumihiro Ishida, MD, Won Seog Kim, MD, Young Hyeh Ko, MD, Junji Suzumiya, MD, Yasushi Isobe, MD, Kazuo Oshimi, MD, Shigeo Nakamura, MD, Ritsuro Suzuki, MD, PhD

Blood (2010) 116 (21): 3091.

https://doi.org/10.1182/blood.V116.21.3091.3091

Published: 2010

Journal Articles

The Efficacy of Bortezomib-CHOP In Patients with Advanced Stage T or NK/T Cell Lymphomas: The Results of Multicenter Phase II Study.

Seok Jin Kim, MD, PhD, Hyeon-Seok Eom, Jin Seok Kim, Hye Jin Kang, Hyo Jung Kim, MD, PhD, Sung-Kyu Park, Jooryung Huh, Young Hyeh Ko, MD, Cheolwon Suh, MD, Won Seog Kim

Blood (2010) 116 (21): 1791.

https://doi.org/10.1182/blood.V116.21.1791.1791

Published: 2010

Journal Articles

NK-Cell Lymphoma Shares Strikingly Similar Molecular Features with a Distinct Set of γδ T-Cell Lymphoma and Identification of Aurora Kinase A Inhibitor as a Novel Therapeutic Agent.

Blood (2009) 114 (22): 313.

https://doi.org/10.1182/blood.V114.22.313.313

Published: 2009

Journal Articles

Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma.

Javeed Iqbal, Ph.D., Dennis Weisenburger, MD, Timothy C. Greiner, MS, MD, Shigeo Nakamura, MD, Julie M. Vose, MD, Masao Seto, MD, PhD, Jan Delabie, MD, Francoise Berger, Florence Loong, MD, Wing-Yan Au, MD, Young-Hyeh Ko, MD, Ivy Sng, MD, Lynette M Smith, MS, Can Kucuk, BS, Huimin Geng, MS, James Armitage, MD, Wing C. Chan, MD

Blood (2008) 112 (11): 3339.

https://doi.org/10.1182/blood.V112.11.3339.3339

Published: 2008

Journal Articles

CS-1 Is Expressed in Nasal Type NK/T Cell Lymphomas and Angioimmunoblastic T-Cell Lymphomas: Implications for Targeted Therapy with Elotuzumab (HuLuc63).

Eric D Hsi, MD, Roxanne Steinle, Balaji Balasa, Audie Rice, PhD, Young-Hyeh Ko, MD, Daniel E.H. Afar, PhD

Blood (2008) 112 (11): 1779.

https://doi.org/10.1182/blood.V112.11.1779.1779

Published: 2008

Journal Articles

Central Nervous System (CNS) Relapse in Extranodal NK/T Cell Lymphoma, Nasal Type: When Do We Need CNS Prophylaxis in Patients with Extranodal NK/T Cell Lymphoma?

Seok Jin Kim, MD, PhD, Sung Hyun Kim, MD, PhD, Jooryung Huh, MD, Young-Hyeh Ko, MD, Hyo-Jin Kim, Cheolwon Suh, Won Seog Kim

Blood (2008) 112 (11): 2833.

https://doi.org/10.1182/blood.V112.11.2833.2833

Published: 2008

Journal Articles

Ocular Adnexal Marginal Zone B Cell Lymphoma Has Characteristic Deletion at Chromosome Band 6q23.3-24.1 Whose Target Is TNFAIP3 .

Keiichiro Honma, MD, Shinobu Tsuzuki, MD, PhD, Masao Nakagawa, MD, PhD, Sivasundaram Karnan, MS, Won-Seog Kim, MD, Yoon-Duk Kim, MD, Young-Hyeh Ko, MD, Masao Seto, MD, PhD

Blood (2007) 110 (11): 2643.

https://doi.org/10.1182/blood.V110.11.2643.2643

Published: 2007

Journal Articles

EBV-Associated Post-Transplant Lymphoproliferative Disorder after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.

Keon Hee Yoo, MD, Hee-Jin Kim, MD, Chang Seok Ki, MD, Ki Woong Sung, MD, Hye Lim Jung, MD, Young Hyeh Ko, MD, Hong-Hoe Koo, MD

Blood (2007) 110 (11): 4980.

https://doi.org/10.1182/blood.V110.11.4980.4980

Published: 2007

Journal Articles

High Incidence of Posttransplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation.

Keon Hee Yoo, MD, Soo Hyun Lee, MD, Ki Woong Sung, MD, Hye Lim Jung, MD, Chang Seok Ki, MD, Young Hyeh Ko, MD, Hong-Hoe Koo, MD

Blood (2006) 108 (11): 5401.

https://doi.org/10.1182/blood.V108.11.5401.5401

Published: 2006

NARROW

Clinical Application of Circulating Tumor DNA in Plasma of Patients with Primary Central Nervous System Lymphoma

PD-L1 Expression in Patients with Primary Central Nervous System Diffuse Large B-Cell Lymphoma: Its Correlation with Serum Levels of Soluble Programmed Death-Ligand 1 (sPD-L1)

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

Prevalence and Prognostic Impact of CD30 and EBV Co-Expression in Korean Patients with EBV-Positive DLBCL of the Elderly

Exome Sequencing of Aggressive Natural Killer Cell Leukemia and Drug Profiling Highlight Candidate Driver Pathways in Malignant Natural Killer Cells

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project.

Aggressive NK Cell Leukemia (ANKL): Experience with 34 Patients and Therapeutic Potentials of L-Asparaginase and Allogeneic Hematopoietic Cell Transplantation - A Japan-Korea Multicenter Study for ANKL (ANKL07) -

The Efficacy of Bortezomib-CHOP In Patients with Advanced Stage T or NK/T Cell Lymphomas: The Results of Multicenter Phase II Study.

NK-Cell Lymphoma Shares Strikingly Similar Molecular Features with a Distinct Set of γδ T-Cell Lymphoma and Identification of Aurora Kinase A Inhibitor as a Novel Therapeutic Agent.

Molecular Signatures to Improve Diagnosis, Prognostication and Identification of Oncogenic Pathways in Peripheral T and NK Cell Lymphoma.

CS-1 Is Expressed in Nasal Type NK/T Cell Lymphomas and Angioimmunoblastic T-Cell Lymphomas: Implications for Targeted Therapy with Elotuzumab (HuLuc63).

Central Nervous System (CNS) Relapse in Extranodal NK/T Cell Lymphoma, Nasal Type: When Do We Need CNS Prophylaxis in Patients with Extranodal NK/T Cell Lymphoma?

Ocular Adnexal Marginal Zone B Cell Lymphoma Has Characteristic Deletion at Chromosome Band 6q23.3-24.1 Whose Target Is TNFAIP3 .

EBV-Associated Post-Transplant Lymphoproliferative Disorder after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.

High Incidence of Posttransplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only